Anti-Periplakin antibody [EPR8296]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(7 Publications)
Rabbit Recombinant Monoclonal Periplakin antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 7 publications.
View Alternative Names
KIAA0568, PPL, Periplakin, 190 kDa paraneoplastic pemphigus antigen, 195 kDa cornified envelope precursor protein
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Periplakin antibody [EPR8296] (AB131269)
Immunohistochemical analysis of paraffin embedded Human skin tissue labelling Periplakin with ab131269 at 1/50 dilution.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-Periplakin antibody [EPR8296] (AB131269)
All lanes:
Western blot - Anti-Periplakin antibody [EPR8296] (ab131269) at 1/1000 dilution
Lane 1:
HACAT lysate at 10 µg
Lane 2:
Human skin lysate at 10 µg
Secondary
All lanes:
Goat anti-Rabbit HRP at 1/2000 dilution
Predicted band size: 205 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-Periplakin antibody [EPR8296] (AB131269)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (1)
-
Anti-Periplakin antibody [EPR8296] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Periplakin participates in the structural organization of epithelial cells. It associates with other proteins to form cytoskeletal linker complexes that enhance cellular stability. As a component of the cornified envelope Periplakin interacts with envoplakin and involucrin. These interactions modulate the cross-linking within the cell envelope impacting the barrier function of the skin and mucous membranes.
Pathways
Periplakin involvement influences epithelial tissue differentiation and stability. It acts within the desmosome assembly pathway impacting cell-cell adhesion processes critical for tissue architecture. Within this pathway Periplakin associates with desmoplakin and envoplakin enhancing cell cohesion and resistance to mechanical stress.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Cells 14: PubMed40710298
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of the European Academy of Dermatology and Venereology : JEADV 37:605-614 PubMed36367625
2022
Applications
Unspecified application
Species
Unspecified reactive species
Translational cancer research 11:1372-1385 PubMed35706781
2022
Applications
Unspecified application
Species
Unspecified reactive species
Discover. Oncology 13:35 PubMed35612641
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 12:6795 PubMed34815391
2021
Applications
Unspecified application
Species
Unspecified reactive species
Plastic and reconstructive surgery. Global open 7:e2339 PubMed31592376
2019
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 9:2357 PubMed30787334
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com